Legal & General Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55K | Buy |
4,013
+138
| +4% | +$1.89K | ﹤0.01% | 2696 |
|
|
2025
Q1 | $42.9K | Sell |
3,875
-15,970
| -80% | -$177K | ﹤0.01% | 2747 |
|
|
2024
Q4 | $211K | Buy |
19,845
+3,920
| +25% | +$41.7K | ﹤0.01% | 2656 |
|
|
2024
Q3 | $202K | Buy |
15,925
+12,311
| +341% | +$156K | ﹤0.01% | 2679 |
|
|
2024
Q2 | $60.6K | Buy |
3,614
+829
| +30% | +$13.9K | ﹤0.01% | 2768 |
|
|
2024
Q1 | $41.8K | Sell |
2,785
-83
| -3% | -$1.25K | ﹤0.01% | 2802 |
|
|
2023
Q4 | $43K | Buy |
2,868
+738
| +35% | +$11.1K | ﹤0.01% | 2827 |
|
|
2023
Q3 | $29.8K | Sell |
2,130
-175
| -8% | -$2.45K | ﹤0.01% | 2923 |
|
|
2023
Q2 | $23.9K | Buy |
+2,305
| New | +$23.9K | ﹤0.01% | 3033 |
|
|
2022
Q2 | – | Sell |
-9,857
| Closed | -$86K | – | 3659 |
|
|
2022
Q1 | $86K | Buy |
9,857
+7,068
| +253% | +$61.7K | ﹤0.01% | 2903 |
|
|
2021
Q4 | $27K | Hold |
2,789
| – | – | ﹤0.01% | 3187 |
|
|
2021
Q3 | $47K | Hold |
2,789
| – | – | ﹤0.01% | 2995 |
|
|
2021
Q2 | $42K | Hold |
2,789
| – | – | ﹤0.01% | 3006 |
|
|
2021
Q1 | $54K | Sell |
2,789
-435
| -13% | -$8.42K | ﹤0.01% | 2794 |
|
|
2020
Q4 | $58K | Hold |
3,224
| – | – | ﹤0.01% | 2763 |
|
|
2020
Q3 | $62K | Sell |
3,224
-803
| -20% | -$15.4K | ﹤0.01% | 2621 |
|
|
2020
Q2 | $105K | Sell |
4,027
-53
| -1% | -$1.38K | ﹤0.01% | 2513 |
|
|
2020
Q1 | $73K | Sell |
4,080
-893
| -18% | -$16K | ﹤0.01% | 2496 |
|
|
2019
Q4 | $166K | Buy |
4,973
+746
| +18% | +$24.9K | ﹤0.01% | 2441 |
|
|
2019
Q3 | $100K | Hold |
4,227
| – | – | ﹤0.01% | 2518 |
|
|
2019
Q2 | $140K | Buy |
4,227
+3,319
| +366% | +$110K | ﹤0.01% | 2436 |
|
|
2019
Q1 | $33K | Buy |
908
+536
| +144% | +$19.5K | ﹤0.01% | 2892 |
|
|
2018
Q4 | $16K | Hold |
372
| – | – | ﹤0.01% | 3174 |
|
|
2018
Q3 | $17K | Hold |
372
| – | – | ﹤0.01% | 3250 |
|
|
2018
Q2 | $18K | Buy |
+372
| New | +$18K | ﹤0.01% | 3215 |
|